This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Junichi Tajiri, MD; Shiro Noguchi, MD; Seiichi Okamura, MD; Mitsuo Morita, MD; Masaaki Tamaru, MD; Nobuo Murakami, MD; Yoshiyuki Niho, MD

Arch Intern Med. 1993;153(4):509-514.

Abstract
The primary objective of this study was to ascertain the effectiveness of granulocyte colonystimulating factor in the treatment of antithyroid drug-induced granulocytopenia of varying degree. Sixteen patients with Graves' disease with antithyroid drug-induced granulocytopenia (granulocyte counts <1.0x10⁹/L) each received a daily dose of 75 µg of granulocyte colony-stimulating factor administered subcutaneously. Within 24 hours of the first injection, the granulocyte count increased (0.6 to 12.3x10⁹/L) in all 10 patients with mild granulocytopenia (granulocyte counts between 0.5 and 1.0x10⁹/L) and all three with moderate granulocytopenia (granulocyte counts <0.5x10⁹/L). The three remaining patients with severe granulocytopenia (agranulocytic), whose granulocyte counts were zero, did not recover from granulocytopenia until the 6th, 7th, and 14th days of treatment with granulocyte colony-stimulating factor. Examination of bone marrow taken at the onset of the disease in all three agranulocytic patients showed a prominent decrease in granulocytic series, while identical examination in six of eight patients with mild to moderate granulocytopenia showed close to normal granulocytic series. There was no elevation of serum granulocyte colony-stimulating factor concentration in four patients with mild granulocytopenia and one with moderate granulocytopenia at the onset of their disease, whereas those of the remaining three patients with severe granulocytopenia (agranulocytic) increased at onset of agranulocytosis. This information led us to conclude that (1) granulocyte colony-stimulating factor is effective in the treatment of antithyroid drug-induced mild to moderate granulocytopenia and (2) in severe agranulocytic cases, granulocyte colony-stimulating factor is not effective. Accordingly, we were again reminded of the importance of early diagnosis and treatment of antithyroid drug-induced agranulocytosis.

(Arch Intern Med. 1993;153:509-514)

Author Affiliations
From the Noguchi Thyroid Clinic and Hospital Foundation, Oita (Drs Tajiri, Noguchi, Morita, Tamaru, and Murakami), and The First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka (Drs Okamura and Niho), Japan. Dr Tajiri is now with the Tajiri Thyroid Clinic, Kumamoto, Japan.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antithyroid Drugs
Cooper
NEJM 2005;352:905-917.
FULL TEXT  

Agranulocytosis Associated With Yohimbine Use
Siddiqui et al.
Arch Intern Med 1996;156:1235-1238.
ABSTRACT  

Agranulocytosis
Young
JAMA 1994;271:935-938.
ABSTRACT  

Monitoring Antithyroid Therapy
Sobel and Glick
Arch Intern Med 1993;153:2797-2797.
ABSTRACT  

Monitoring Antithyroid Therapy-Reply
Tajiri et al.
Arch Intern Med 1993;153:2797-2797.
ABSTRACT